These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17599696)

  • 21. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of beta-amyloid and tau protein aggregations on magnetic susceptibility of anterior hippocampal laminae in Alzheimer's diseases.
    Zhao Z; Zhang L; Wen Q; Luo W; Zheng W; Liu T; Zhang Y; Zhu K; Wu D
    Neuroimage; 2021 Dec; 244():118584. PubMed ID: 34537383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease.
    Velickaite V; Giedraitis V; Ström K; Alafuzoff I; Zetterberg H; Lannfelt L; Kilander L; Larsson EM; Ingelsson M
    BMC Geriatr; 2017 Sep; 17(1):208. PubMed ID: 28886705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MCI patients' EEGs show group differences between those who progress and those who do not progress to AD.
    Moretti DV; Frisoni GB; Fracassi C; Pievani M; Geroldi C; Binetti G; Rossini PM; Zanetti O
    Neurobiol Aging; 2011 Apr; 32(4):563-71. PubMed ID: 20022139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
    Pennanen C; Kivipelto M; Tuomainen S; Hartikainen P; Hänninen T; Laakso MP; Hallikainen M; Vanhanen M; Nissinen A; Helkala EL; Vainio P; Vanninen R; Partanen K; Soininen H
    Neurobiol Aging; 2004 Mar; 25(3):303-10. PubMed ID: 15123335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of Alzheimer's disease in a population attending a memory clinic.
    Frisoni GB; Prestia A; Zanetti O; Galluzzi S; Romano M; Cotelli M; Gennarelli M; Binetti G; Bocchio L; Paghera B; Amicucci G; Bonetti M; Benussi L; Ghidoni R; Geroldi C
    Alzheimers Dement; 2009 Jul; 5(4):307-17. PubMed ID: 19560101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease.
    Tan RH; Pok K; Wong S; Brooks D; Halliday GM; Kril JJ
    Acta Neuropathol Commun; 2013 Jul; 1():30. PubMed ID: 24252534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.
    Lorenzi M; Donohue M; Paternicò D; Scarpazza C; Ostrowitzki S; Blin O; Irving E; Frisoni GB;
    Neurobiol Aging; 2010 Aug; 31(8):1443-51, 1451.e1. PubMed ID: 20541287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
    Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
    Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF-tau and CSF-Abeta(1-42) in posterior cortical atrophy.
    Baumann TP; Duyar H; Sollberger M; Kuhle J; Regeniter A; Gomez-Mancilla B; Schmidtke K; Monsch AU
    Dement Geriatr Cogn Disord; 2010; 29(6):530-3. PubMed ID: 20606434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebral imaging and physiopathology of Alzheimer's disease].
    Fouquet M; Villain N; Chételat G; Eustache F; Desgranges B
    Psychol Neuropsychiatr Vieil; 2007 Dec; 5(4):269-79. PubMed ID: 18048105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease.
    Burke WJ; Galvin NJ; Chung HD; Stoff SA; Gillespie KN; Cataldo AM; Nixon RA
    Brain Res; 1994 Oct; 661(1-2):35-42. PubMed ID: 7834382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.